HEADER HYDROLASE 18-OCT-05 2C4F
TITLE CRYSTAL STRUCTURE OF FACTOR VII.STF COMPLEXED WITH PD0297121
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: COAGULATION FACTOR VII PRECURSOR;
COMPND 3 CHAIN: H;
COMPND 4 FRAGMENT: FACTOR VII HEAVY CHAIN, RESIDUES 213-466;
COMPND 5 SYNONYM: FACTOR VII, SERUM PROTHROMBIN CONVERSION ACCELERATOR, SPCA,
COMPND 6 PROCONVERTIN, EPTACOG ALFA;
COMPND 7 EC: 3.4.21.21;
COMPND 8 ENGINEERED: YES;
COMPND 9 MOL_ID: 2;
COMPND 10 MOLECULE: COAGULATION FACTOR VII PRECURSOR;
COMPND 11 CHAIN: L;
COMPND 12 FRAGMENT: FACTOR VII LIGHT CHAIN, RESIDUES 61-202;
COMPND 13 SYNONYM: FACTOR VII, SERUM PROTHROMBIN CONVERSION ACCELERATOR, SPCA,
COMPND 14 PROCONVERTIN, EPTACOG ALFA;
COMPND 15 EC: 3.4.21.21;
COMPND 16 ENGINEERED: YES;
COMPND 17 MOL_ID: 3;
COMPND 18 MOLECULE: TISSUE FACTOR PRECURSOR;
COMPND 19 CHAIN: T;
COMPND 20 FRAGMENT: FACTOR III, RESIDUES 38-112;
COMPND 21 SYNONYM: TISSUE FACTOR, TF, COAGULATION FACTOR III THROMBOPLASTIN,
COMPND 22 CD142 ANTIGEN;
COMPND 23 ENGINEERED: YES;
COMPND 24 MOL_ID: 4;
COMPND 25 MOLECULE: TISSUE FACTOR PRECURSOR;
COMPND 26 CHAIN: U;
COMPND 27 FRAGMENT: FACTOR III, RESIDUES 123-242;
COMPND 28 SYNONYM: TISSUE FACTOR, TF, COAGULATION FACTOR III THROMBOPLASTIN,
COMPND 29 CD142 ANTIGEN;
COMPND 30 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 SYNTHETIC: YES;
SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 MOL_ID: 2;
SOURCE 6 SYNTHETIC: YES;
SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 8 ORGANISM_TAXID: 9606;
SOURCE 9 MOL_ID: 3;
SOURCE 10 SYNTHETIC: YES;
SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 12 ORGANISM_TAXID: 9606;
SOURCE 13 MOL_ID: 4;
SOURCE 14 SYNTHETIC: YES;
SOURCE 15 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 16 ORGANISM_TAXID: 9606
KEYWDS BLOOD COAGULATION, SERINE PROTEASE, EGF, EGF-LIKE DOMAIN, GLA,
KEYWDS 2 RECEPTOR ENZYME, GLYCOPROTEIN, HYDROLASE, PROTEASE, HYDROXYLATION,
KEYWDS 3 LIPOPROTEIN, PALMITATE, TRANSMEMBRANE
EXPDTA X-RAY DIFFRACTION
AUTHOR J.T.KOHRT,E.ZHANG
REVDAT 6 29-JUL-20 2C4F 1 COMPND REMARK HETNAM LINK
REVDAT 6 2 1 SITE
REVDAT 5 22-MAY-19 2C4F 1 REMARK
REVDAT 4 12-JUL-17 2C4F 1
REVDAT 3 24-FEB-09 2C4F 1 VERSN
REVDAT 2 21-DEC-06 2C4F 1 ATOM
REVDAT 1 18-OCT-06 2C4F 0
JRNL AUTH J.T.KOHRT,K.J.FILIPSKI,W.L.CODY,C.CAI,D.A.DUDLEY,C.A.V.HUIS,
JRNL AUTH 2 J.A.WILLARDSEN,L.S.NARASIMHAN,E.ZHANG,S.T.RAPUNDALO,
JRNL AUTH 3 K.SAIYA-CORK,R.J.LEADLEY,J.J.EDMUNDS
JRNL TITL THE DISCOVERY OF FLUOROPYRIDINE-BASED INHIBITORS OF THE
JRNL TITL 2 FACTOR VIIA/TF COMPLEX--PART 2
JRNL REF BIOORG.MED.CHEM.LETT. V. 16 1060 2006
JRNL REFN ISSN 0960-894X
JRNL PMID 16289811
JRNL DOI 10.1016/J.BMCL.2005.10.076
REMARK 2
REMARK 2 RESOLUTION. 1.72 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNS
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN
REMARK 3
REMARK 3 REFINEMENT TARGET : NULL
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.72
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000.000
REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 88.8
REMARK 3 NUMBER OF REFLECTIONS : 69287
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : NULL
REMARK 3 R VALUE (WORKING SET) : 0.229
REMARK 3 FREE R VALUE : NULL
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.500
REMARK 3 FREE R VALUE TEST SET COUNT : 3542
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : NULL
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL
REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL
REMARK 3 BIN R VALUE (WORKING SET) : NULL
REMARK 3 BIN FREE R VALUE : NULL
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 4646
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 84
REMARK 3 SOLVENT ATOMS : 328
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -0.16000
REMARK 3 B22 (A**2) : 0.09400
REMARK 3 B33 (A**2) : 0.06600
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM SIGMAA (A) : NULL
REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM C-V SIGMAA (A) : NULL
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.005
REMARK 3 BOND ANGLES (DEGREES) : 1.330
REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL
REMARK 3 IMPROPER ANGLES (DEGREES) : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : NULL
REMARK 3 KSOL : NULL
REMARK 3 BSOL : 44.99
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM
REMARK 3 PARAMETER FILE 2 : CARBOHYDRATE.PARAM
REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM
REMARK 3 PARAMETER FILE 4 : ION.PARAM
REMARK 3 PARAMETER FILE 5 : LIG.PARAM
REMARK 3 PARAMETER FILE 6 : NULL
REMARK 3 TOPOLOGY FILE 1 : NULL
REMARK 3 TOPOLOGY FILE 2 : NULL
REMARK 3 TOPOLOGY FILE 3 : NULL
REMARK 3 TOPOLOGY FILE 4 : NULL
REMARK 3 TOPOLOGY FILE 5 : NULL
REMARK 3 TOPOLOGY FILE 6 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 2C4F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 18-OCT-05.
REMARK 100 THE DEPOSITION ID IS D_1290026024.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : NULL
REMARK 200 TEMPERATURE (KELVIN) : 100.0
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : NULL
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.000
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : NULL
REMARK 200 DETECTOR MANUFACTURER : NULL
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL
REMARK 200 DATA SCALING SOFTWARE : NULL
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 74832
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.720
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 96.9
REMARK 200 DATA REDUNDANCY : 4.500
REMARK 200 R MERGE (I) : 0.04000
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 34.6000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER
REMARK 200 SOFTWARE USED: NULL
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 51.66
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.56
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: NULL
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 35.49650
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 62.93000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.65100
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 62.93000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.49650
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.65100
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC
REMARK 350 SOFTWARE USED: PQS
REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, L, T, U
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 400
REMARK 400 COMPOUND
REMARK 400 FACTOR VII INITIATES THE EXTRINSIC PATHWAY OF BLOOD COAGULATION.
REMARK 400 TISSUE FACTOR INITIATES BLOOD COAGULATION BY FORMING A COMPLEX WITH
REMARK 400 FACTOR VII.
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 ALA L 1
REMARK 465 ASN L 2
REMARK 465 ALA L 3
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 HIS H 199 N - CA - C ANGL. DEV. = -17.7 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ASN H 60D 77.98 -102.06
REMARK 500 ASN H 63 40.16 -108.34
REMARK 500 HIS H 71 -57.65 -146.86
REMARK 500 THR H 129C -57.73 -120.45
REMARK 500 ASP H 170G 46.36 -98.20
REMARK 500 SER H 214 -67.62 -120.16
REMARK 500 CGU L 19 -71.45 -64.30
REMARK 500 ASP L 33 124.70 -171.15
REMARK 500 GLN L 100 -92.53 -120.47
REMARK 500 THR L 108 -139.85 -128.54
REMARK 500 PHE T 19 -3.81 73.69
REMARK 500 ASP T 66 93.14 -166.04
REMARK 500 ARG U 136 84.08 -170.53
REMARK 500 ASN U 137 67.85 70.12
REMARK 500 ASN U 138 14.87 57.32
REMARK 500 THR U 172 -147.11 -117.28
REMARK 500
REMARK 500 REMARK: NULL
REMARK 620
REMARK 620 METAL COORDINATION
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 CA H 301 CA
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 GLU H 70 OE1
REMARK 620 2 ASP H 72 O 88.6
REMARK 620 3 GLU H 75 O 170.4 82.1
REMARK 620 4 GLU H 80 OE2 94.2 177.0 95.1
REMARK 620 5 HOH H 430 O 92.9 84.8 84.0 93.9
REMARK 620 6 HOH H 509 O 86.2 92.1 96.4 89.2 176.9
REMARK 620 N 1 2 3 4 5
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 CA L 205 CA
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 CGU L 14 OE12
REMARK 620 2 CGU L 14 OE21 82.6
REMARK 620 3 CGU L 19 OE12 171.5 103.1
REMARK 620 4 CGU L 19 OE21 78.3 87.9 95.6
REMARK 620 N 1 2 3
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 CA L 204 CA
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 CGU L 16 OE11
REMARK 620 2 CGU L 16 OE21 78.1
REMARK 620 3 CGU L 26 OE11 167.6 94.2
REMARK 620 4 CGU L 26 OE22 94.6 101.8 77.3
REMARK 620 N 1 2 3
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 CA L 206 CA
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 CGU L 25 OE11
REMARK 620 2 CGU L 25 OE21 92.3
REMARK 620 3 CGU L 29 OE11 176.4 90.8
REMARK 620 4 CGU L 29 OE21 88.7 93.9 89.4
REMARK 620 5 HOH L 301 O 95.6 82.3 86.6 174.4
REMARK 620 N 1 2 3 4
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 CA L 201 CA
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 ASP L 46 OD2
REMARK 620 2 GLY L 47 O 91.6
REMARK 620 3 GLN L 49 OE1 85.9 80.8
REMARK 620 4 ASP L 63 OD1 151.4 95.5 68.1
REMARK 620 5 ASP L 63 OD2 154.1 98.3 119.1 51.3
REMARK 620 6 GLN L 64 O 86.0 160.1 79.3 78.0 92.2
REMARK 620 7 HOH L 344 O 79.9 82.4 157.7 128.4 77.8 116.5
REMARK 620 N 1 2 3 4 5 6
REMARK 700
REMARK 700 SHEET
REMARK 700 DETERMINATION METHOD: DSSP
REMARK 700 THE SHEETS PRESENTED AS "HA" IN EACH CHAIN ON SHEET RECORDS
REMARK 700 BELOW IS ACTUALLY AN 8-STRANDED BARREL THIS IS REPRESENTED BY
REMARK 700 A 9-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS
REMARK 700 ARE IDENTICAL.
REMARK 700 THE SHEETS PRESENTED AS "HB" IN EACH CHAIN ON SHEET RECORDS
REMARK 700 BELOW IS ACTUALLY AN 8-STRANDED BARREL THIS IS REPRESENTED BY
REMARK 700 A 9-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS
REMARK 700 ARE IDENTICAL.
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1AHW RELATED DB: PDB
REMARK 900 A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN
REMARK 900 INHIBITORY FAB (5G9)
REMARK 900 RELATED ID: 1BOY RELATED DB: PDB
REMARK 900 EXTRACELLULAR REGION OF HUMAN TISSUE FACTOR
REMARK 900 RELATED ID: 1BF9 RELATED DB: PDB
REMARK 900 N-TERMINAL EGF-LIKE DOMAIN FROM HUMAN FACTOR VII, NMR, 23 STRUCTURES
REMARK 900 RELATED ID: 1TFH RELATED DB: PDB
REMARK 900 EXTRACELLULAR DOMAIN OF HUMAN TISSUE FACTOR
REMARK 900 RELATED ID: 1UJ3 RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF A HUMANIZED FAB FRAGMENT OF ANTI-TISSUE-FACTOR
REMARK 900 ANTIBODY IN COMPLEX WITH TISSUE FACTOR
REMARK 900 RELATED ID: 2HFT RELATED DB: PDB
REMARK 900 MOL_ID: 1; MOLECULE: HUMAN TISSUE FACTOR; CHAIN: NULL; DOMAIN:
REMARK 900 EXTRACELLULAR DOMAIN, RESIDUES 1 - 219; ENGINEERED: YES
REMARK 900 RELATED ID: 1CVW RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF ACTIVE SITE-INHIBITED HUMAN COAGULATION FACTOR
REMARK 900 VIIA (DES-GLA)
REMARK 900 RELATED ID: 1DAN RELATED DB: PDB
REMARK 900 COMPLEX OF ACTIVE SITE INHIBITED HUMAN BLOOD COAGULATION FACTOR
REMARK 900 VIIA WITH HUMAN RECOMBINANT SOLUBLE TISSUE FACTOR
REMARK 900 RELATED ID: 1DVA RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE PEPTIDE EXOSITE
REMARK 900 INHIBITOR E-76 AND COAGULATION FACTOR VIIA
REMARK 900 RELATED ID: 1F7E RELATED DB: PDB
REMARK 900 THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII, NMR,
REMARK 900 20 STRUCTURES
REMARK 900 RELATED ID: 1F7M RELATED DB: PDB
REMARK 900 THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII, NMR,
REMARK 900 MINIMIZED AVERAGE STRUCTURE
REMARK 900 RELATED ID: 1FAK RELATED DB: PDB
REMARK 900 HUMAN TISSUE FACTOR COMPLEXED WITH COAGULATION FACTOR VIIA
REMARK 900 INHIBITED WITH A BPTI-MUTANT
REMARK 900 RELATED ID: 1FF7 RELATED DB: PDB
REMARK 900 THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII
REMARK 900 (FUCOSYLATED AT SER-60), NMR, 20 STRUCTURES
REMARK 900 RELATED ID: 1FFM RELATED DB: PDB
REMARK 900 THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII
REMARK 900 (FUCOSYLATED AT SER-60), NMR, MINIMIZED AVERAGE STRUCTURE
REMARK 900 RELATED ID: 1J9C RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF TISSUE FACTOR-FACTOR VIIA COMPLEX
REMARK 900 RELATED ID: 1JPS RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF TISSUE FACTOR IN COMPLEX WITHHUMANIZED FAB
REMARK 900 D3H44
REMARK 900 RELATED ID: 1JBU RELATED DB: PDB
REMARK 900 COAGULATION FACTOR VII ZYMOGEN (EGF2/PROTEASE) IN COMPLEXWITH
REMARK 900 INHIBITORY EXOSITE PEPTIDE A -183
REMARK 900 RELATED ID: 1KLI RELATED DB: PDB
REMARK 900 COFACTOR-AND SUBSTRATE-ASSISTED ACTIVATION OF FACTOR VIIA
REMARK 900 RELATED ID: 1KLJ RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF UNINHIBITED FACTOR VIIA
REMARK 900 RELATED ID: 1NL8 RELATED DB: PDB
REMARK 900 THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX
REMARK 900 RELATED ID: 1O5D RELATED DB: PDB
REMARK 900 DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTSAT THE
REMARK 900 S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190UPA)
REMARK 900 RELATED ID: 1QFK RELATED DB: PDB
REMARK 900 STRUCTURE OF HUMAN FACTOR VIIA AND ITS IMPLICATIONS FOR THE
REMARK 900 TRIGGERING OF BLOOD COAGULATION
REMARK 900 RELATED ID: 1W0Y RELATED DB: PDB
REMARK 900 TF7A_3771 COMPLEX
REMARK 900 RELATED ID: 1W2K RELATED DB: PDB
REMARK 900 TF7A_4380 COMPLEX
REMARK 900 RELATED ID: 1W7X RELATED DB: PDB
REMARK 900 FACTOR7 - 413 COMPLEX
REMARK 900 RELATED ID: 1W8B RELATED DB: PDB
REMARK 900 FACTOR7 - 413 COMPLEX
REMARK 900 RELATED ID: 1WQV RELATED DB: PDB
REMARK 900 HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITHPROPYLSULFONAMIDE-D-
REMARK 900 THR-MET-P- AMINOBENZAMIDINE
REMARK 900 RELATED ID: 1YGC RELATED DB: PDB
REMARK 900 SHORT FACTOR VIIA WITH A SMALL MOLECULE INHIBITOR
REMARK 900 RELATED ID: 1Z6J RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF FACTORVIIA/TISSUE FACTOR/
REMARK 900 PYRAZINONE INHIBITOR
REMARK 900 RELATED ID: 2BZ6 RELATED DB: PDB
REMARK 900 ORALLY AVAILABLE FACTOR7A INHIBITOR
DBREF 2C4F H 16 257 UNP P08709 FA7_HUMAN 213 466
DBREF 2C4F L 1 142 UNP P08709 FA7_HUMAN 61 202
DBREF 2C4F T 6 80 UNP P13726 TF_HUMAN 38 112
DBREF 2C4F U 91 210 UNP P13726 TF_HUMAN 123 242
SEQRES 1 H 254 ILE VAL GLY GLY LYS VAL CYS PRO LYS GLY GLU CYS PRO
SEQRES 2 H 254 TRP GLN VAL LEU LEU LEU VAL ASN GLY ALA GLN LEU CYS
SEQRES 3 H 254 GLY GLY THR LEU ILE ASN THR ILE TRP VAL VAL SER ALA
SEQRES 4 H 254 ALA HIS CYS PHE ASP LYS ILE LYS ASN TRP ARG ASN LEU
SEQRES 5 H 254 ILE ALA VAL LEU GLY GLU HIS ASP LEU SER GLU HIS ASP
SEQRES 6 H 254 GLY ASP GLU GLN SER ARG ARG VAL ALA GLN VAL ILE ILE
SEQRES 7 H 254 PRO SER THR TYR VAL PRO GLY THR THR ASN HIS ASP ILE
SEQRES 8 H 254 ALA LEU LEU ARG LEU HIS GLN PRO VAL VAL LEU THR ASP
SEQRES 9 H 254 HIS VAL VAL PRO LEU CYS LEU PRO GLU ARG THR PHE SER
SEQRES 10 H 254 GLU ARG THR LEU ALA PHE VAL ARG PHE SER LEU VAL SER
SEQRES 11 H 254 GLY TRP GLY GLN LEU LEU ASP ARG GLY ALA THR ALA LEU
SEQRES 12 H 254 GLU LEU MET VAL LEU ASN VAL PRO ARG LEU MET THR GLN
SEQRES 13 H 254 ASP CYS LEU GLN GLN SER ARG LYS VAL GLY ASP SER PRO
SEQRES 14 H 254 ASN ILE THR GLU TYR MET PHE CYS ALA GLY TYR SER ASP
SEQRES 15 H 254 GLY SER LYS ASP SER CYS LYS GLY ASP SER GLY GLY PRO
SEQRES 16 H 254 HIS ALA THR HIS TYR ARG GLY THR TRP TYR LEU THR GLY
SEQRES 17 H 254 ILE VAL SER TRP GLY GLN GLY CYS ALA THR VAL GLY HIS
SEQRES 18 H 254 PHE GLY VAL TYR THR ARG VAL SER GLN TYR ILE GLU TRP
SEQRES 19 H 254 LEU GLN LYS LEU MET ARG SER GLU PRO ARG PRO GLY VAL
SEQRES 20 H 254 LEU LEU ARG ALA PRO PHE PRO
SEQRES 1 L 142 ALA ASN ALA PHE LEU CGU CGU LEU ARG PRO GLY SER LEU
SEQRES 2 L 142 CGU ARG CGU CYS LYS CGU CGU GLN CYS SER PHE CGU CGU
SEQRES 3 L 142 ALA ARG CGU ILE PHE LYS ASP ALA CGU ARG THR LYS LEU
SEQRES 4 L 142 PHE TRP ILE SER TYR SER ASP GLY ASP GLN CYS ALA SER
SEQRES 5 L 142 SER PRO CYS GLN ASN GLY GLY SER CYS LYS ASP GLN LEU
SEQRES 6 L 142 GLN SER TYR ILE CYS PHE CYS LEU PRO ALA PHE GLU GLY
SEQRES 7 L 142 ARG ASN CYS GLU THR HIS LYS ASP ASP GLN LEU ILE CYS
SEQRES 8 L 142 VAL ASN GLU ASN GLY GLY CYS GLU GLN TYR CYS SER ASP
SEQRES 9 L 142 HIS THR GLY THR LYS ARG SER CYS ARG CYS HIS GLU GLY
SEQRES 10 L 142 TYR SER LEU LEU ALA ASP GLY VAL SER CYS THR PRO THR
SEQRES 11 L 142 VAL GLU TYR PRO CYS GLY LYS ILE PRO ILE LEU GLU
SEQRES 1 T 75 THR VAL ALA ALA TYR ASN LEU THR TRP LYS SER THR ASN
SEQRES 2 T 75 PHE LYS THR ILE LEU GLU TRP GLU PRO LYS PRO VAL ASN
SEQRES 3 T 75 GLN VAL TYR THR VAL GLN ILE SER THR LYS SER GLY ASP
SEQRES 4 T 75 TRP LYS SER LYS CYS PHE TYR THR THR ASP THR GLU CYS
SEQRES 5 T 75 ASP LEU THR ASP GLU ILE VAL LYS ASP VAL LYS GLN THR
SEQRES 6 T 75 TYR LEU ALA ARG VAL PHE SER TYR PRO ALA
SEQRES 1 U 116 GLU PRO LEU TYR GLU ASN SER PRO GLU PHE THR PRO TYR
SEQRES 2 U 116 LEU GLU THR ASN LEU GLY GLN PRO THR ILE GLN SER PHE
SEQRES 3 U 116 GLU GLN VAL GLY THR LYS VAL ASN VAL THR VAL GLU ASP
SEQRES 4 U 116 GLU ARG THR LEU VAL ARG ARG ASN ASN THR PHE LEU SER
SEQRES 5 U 116 LEU ARG ASP VAL PHE GLY LYS ASP LEU ILE TYR THR LEU
SEQRES 6 U 116 TYR TYR TRP SER GLY LYS LYS THR ALA LYS THR ASN THR
SEQRES 7 U 116 ASN GLU PHE LEU ILE ASP VAL ASP LYS GLY GLU ASN TYR
SEQRES 8 U 116 CYS PHE SER VAL GLN ALA VAL ILE PRO SER ARG THR VAL
SEQRES 9 U 116 ASN ARG LYS SER THR ASP SER PRO VAL GLU CYS MET
MODRES 2C4F ASN U 124 ASN GLYCOSYLATION SITE
MODRES 2C4F CGU L 6 GLU GAMMA-CARBOXY-GLUTAMIC ACID
MODRES 2C4F CGU L 7 GLU GAMMA-CARBOXY-GLUTAMIC ACID
MODRES 2C4F CGU L 14 GLU GAMMA-CARBOXY-GLUTAMIC ACID
MODRES 2C4F CGU L 16 GLU GAMMA-CARBOXY-GLUTAMIC ACID
MODRES 2C4F CGU L 19 GLU GAMMA-CARBOXY-GLUTAMIC ACID
MODRES 2C4F CGU L 20 GLU GAMMA-CARBOXY-GLUTAMIC ACID
MODRES 2C4F CGU L 25 GLU GAMMA-CARBOXY-GLUTAMIC ACID
MODRES 2C4F CGU L 26 GLU GAMMA-CARBOXY-GLUTAMIC ACID
MODRES 2C4F CGU L 29 GLU GAMMA-CARBOXY-GLUTAMIC ACID
MODRES 2C4F CGU L 35 GLU GAMMA-CARBOXY-GLUTAMIC ACID
HET CGU L 6 12
HET CGU L 7 12
HET CGU L 14 12
HET CGU L 16 12
HET CGU L 19 12
HET CGU L 20 12
HET CGU L 25 12
HET CGU L 26 12
HET CGU L 29 12
HET CGU L 35 12
HET CA H 301 1
HET GIL H 302 42
HET CA L 201 1
HET GLC L 202 12
HET FUC L 203 11
HET CA L 204 1
HET CA L 205 1
HET CA L 206 1
HET NAG U 301 14
HETNAM CGU GAMMA-CARBOXY-GLUTAMIC ACID
HETNAM CA CALCIUM ION
HETNAM GIL 2-{[6-{3-[AMINO(IMINO)METHYL]PHENOXY}-4-
HETNAM 2 GIL (DIISOPROPYLAMINO)-3,5-DIFLUOROPYRIDIN-2-YL]OXY}-5-
HETNAM 3 GIL [(ISOBUTYLAMINO)CARBONYL]BEN ZOIC ACID
HETNAM GLC ALPHA-D-GLUCOPYRANOSE
HETNAM FUC ALPHA-L-FUCOPYRANOSE
HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE
HETSYN GIL PD0297121
FORMUL 2 CGU 10(C6 H9 N O6)
FORMUL 5 CA 5(CA 2+)
FORMUL 6 GIL C30 H35 F2 N5 O5
FORMUL 8 GLC C6 H12 O6
FORMUL 9 FUC C6 H12 O5
FORMUL 13 NAG C8 H15 N O6
FORMUL 14 HOH *328(H2 O)
HELIX 1 1 ALA H 55 ASP H 60 5 6
HELIX 2 2 GLU H 125 THR H 129C 1 8
HELIX 3 3 LEU H 129D VAL H 129G 5 4
HELIX 4 4 MET H 164 SER H 170B 1 9
HELIX 5 5 TYR H 234 MET H 242 1 9
HELIX 6 6 ARG L 36 SER L 45 1 10
HELIX 7 7 ASP L 48 SER L 53 5 6
HELIX 8 8 ASP L 86 GLN L 88 5 3
HELIX 9 9 ASN L 93 CYS L 98 5 6
HELIX 10 10 LEU T 59 VAL T 64 1 6
HELIX 11 11 THR U 101 THR U 106 1 6
HELIX 12 12 LEU U 143 GLY U 148 1 6
HELIX 13 13 LYS U 149 LEU U 151 5 3
SHEET 1 HA 9 LYS H 20 VAL H 21 0
SHEET 2 HA 9 MET H 156 LEU H 163 -1 O VAL H 157 N LYS H 20
SHEET 3 HA 9 MET H 180 ALA H 183 -1 O CYS H 182 N LEU H 163
SHEET 4 HA 9 GLY H 226 ARG H 230 -1 O GLY H 226 N ALA H 183
SHEET 5 HA 9 THR H 206 TRP H 215 -1 O ILE H 212 N THR H 229
SHEET 6 HA 9 PRO H 198 TYR H 203 -1 O HIS H 199 N THR H 210
SHEET 7 HA 9 PHE H 135 GLY H 140 -1 O LEU H 137 N ALA H 200
SHEET 8 HA 9 MET H 156 LEU H 163 1 O MET H 156 N GLY H 140
SHEET 9 HA 9 LYS H 20 VAL H 21 -1 O LYS H 20 N VAL H 157
SHEET 1 HB 9 GLN H 30 VAL H 35 0
SHEET 2 HB 9 ALA H 39 LEU H 46 -1 O ALA H 39 N VAL H 35
SHEET 3 HB 9 TRP H 51 SER H 54 -1 O VAL H 53 N THR H 45
SHEET 4 HB 9 ALA H 104 LEU H 108 -1 O ALA H 104 N SER H 54
SHEET 5 HB 9 GLN H 81 PRO H 91 1 N ALA H 86 O ARG H 107
SHEET 6 HB 9 LEU H 64 LEU H 68 -1 O LEU H 64 N VAL H 85
SHEET 7 HB 9 GLN H 30 VAL H 35 -1 O LEU H 32 N VAL H 67
SHEET 8 HB 9 ALA H 39 LEU H 46 -1 O ALA H 39 N VAL H 35
SHEET 9 HB 9 GLN H 30 VAL H 35 -1 O VAL H 31 N GLY H 44
SHEET 1 LA 2 SER L 60 GLN L 64 0
SHEET 2 LA 2 SER L 67 PHE L 71 -1 O SER L 67 N GLN L 64
SHEET 1 LB 2 PHE L 76 GLU L 77 0
SHEET 2 LB 2 THR L 83 HIS L 84 -1 O THR L 83 N GLU L 77
SHEET 1 LC 2 TYR L 101 SER L 103 0
SHEET 2 LC 2 SER L 111 ARG L 113 -1 O SER L 111 N SER L 103
SHEET 1 LD 2 TYR L 118 LEU L 120 0
SHEET 2 LD 2 CYS L 127 PRO L 129 -1 O THR L 128 N SER L 119
SHEET 1 TA 3 TYR T 10 THR T 17 0
SHEET 2 TA 3 LYS T 20 GLU T 26 -1 O LYS T 20 N THR T 17
SHEET 3 TA 3 GLU T 56 ASP T 58 -1 O CYS T 57 N LEU T 23
SHEET 1 TB 4 LYS T 46 THR T 52 0
SHEET 2 TB 4 GLN T 32 THR T 40 -1 O TYR T 34 N THR T 52
SHEET 3 TB 4 TYR T 71 PRO T 79 -1 O LEU T 72 N SER T 39
SHEET 4 TB 4 LEU U 93 ASN U 96 -1 O LEU U 93 N SER T 77
SHEET 1 UA 3 ILE U 113 VAL U 119 0
SHEET 2 UA 3 LYS U 122 VAL U 127 -1 O LYS U 122 N VAL U 119
SHEET 3 UA 3 GLU U 174 ASP U 178 -1 O PHE U 175 N VAL U 125
SHEET 1 UB 2 ARG U 131 ARG U 135 0
SHEET 2 UB 2 PHE U 140 SER U 142 -1 O LEU U 141 N THR U 132
SHEET 1 UC 4 LYS U 166 THR U 170 0
SHEET 2 UC 4 ILE U 152 TRP U 158 -1 O TYR U 153 N THR U 170
SHEET 3 UC 4 CYS U 186 VAL U 192 -1 O CYS U 186 N TRP U 158
SHEET 4 UC 4 GLU U 208 CYS U 209 -1 O GLU U 208 N PHE U 187
SSBOND 1 CYS H 22 CYS H 27 1555 1555 2.04
SSBOND 2 CYS H 42 CYS H 58 1555 1555 2.04
SSBOND 3 CYS H 122 CYS L 135 1555 1555 2.03
SSBOND 4 CYS H 168 CYS H 182 1555 1555 2.03
SSBOND 5 CYS H 191 CYS H 220 1555 1555 2.02
SSBOND 6 CYS L 17 CYS L 22 1555 1555 2.03
SSBOND 7 CYS L 50 CYS L 61 1555 1555 2.03
SSBOND 8 CYS L 55 CYS L 70 1555 1555 2.03
SSBOND 9 CYS L 72 CYS L 81 1555 1555 2.04
SSBOND 10 CYS L 91 CYS L 102 1555 1555 2.03
SSBOND 11 CYS L 98 CYS L 112 1555 1555 2.04
SSBOND 12 CYS L 114 CYS L 127 1555 1555 2.03
SSBOND 13 CYS T 49 CYS T 57 1555 1555 2.04
SSBOND 14 CYS U 186 CYS U 209 1555 1555 2.03
LINK C LEU L 5 N CGU L 6 1555 1555 1.34
LINK C CGU L 6 N CGU L 7 1555 1555 1.34
LINK C CGU L 7 N LEU L 8 1555 1555 1.38
LINK C LEU L 13 N CGU L 14 1555 1555 1.35
LINK C CGU L 14 N ARG L 15 1555 1555 1.38
LINK C ARG L 15 N CGU L 16 1555 1555 1.35
LINK C CGU L 16 N CYS L 17 1555 1555 1.38
LINK C LYS L 18 N CGU L 19 1555 1555 1.34
LINK C CGU L 19 N CGU L 20 1555 1555 1.34
LINK C CGU L 20 N GLN L 21 1555 1555 1.38
LINK C PHE L 24 N CGU L 25 1555 1555 1.34
LINK C CGU L 25 N CGU L 26 1555 1555 1.34
LINK C CGU L 26 N ALA L 27 1555 1555 1.37
LINK C ARG L 28 N CGU L 29 1555 1555 1.34
LINK C CGU L 29 N ILE L 30 1555 1555 1.38
LINK C ALA L 34 N CGU L 35 1555 1555 1.34
LINK C CGU L 35 N ARG L 36 1555 1555 1.38
LINK ND2 ASN U 124 C1 NAG U 301 1555 1555 1.45
LINK OE1 GLU H 70 CA CA H 301 1555 1555 2.21
LINK O ASP H 72 CA CA H 301 1555 1555 2.24
LINK O GLU H 75 CA CA H 301 1555 1555 2.10
LINK OE2 GLU H 80 CA CA H 301 1555 1555 2.11
LINK CA CA H 301 O HOH H 430 1555 1555 2.19
LINK CA CA H 301 O HOH H 509 1555 1555 2.15
LINK OE12 CGU L 14 CA CA L 205 1555 1555 2.65
LINK OE21 CGU L 14 CA CA L 205 1555 1555 2.46
LINK OE11 CGU L 16 CA CA L 204 1555 1555 2.14
LINK OE21 CGU L 16 CA CA L 204 1555 1555 2.12
LINK OE12 CGU L 19 CA CA L 205 1555 1555 2.38
LINK OE21 CGU L 19 CA CA L 205 1555 1555 2.25
LINK OE11 CGU L 25 CA CA L 206 1555 1555 2.11
LINK OE21 CGU L 25 CA CA L 206 1555 1555 2.23
LINK OE11 CGU L 26 CA CA L 204 1555 1555 2.12
LINK OE22 CGU L 26 CA CA L 204 1555 1555 2.23
LINK OE11 CGU L 29 CA CA L 206 1555 1555 2.29
LINK OE21 CGU L 29 CA CA L 206 1555 1555 2.20
LINK OD2 ASP L 46 CA CA L 201 1555 1555 2.22
LINK O GLY L 47 CA CA L 201 1555 1555 2.32
LINK OE1 GLN L 49 CA CA L 201 1555 1555 2.36
LINK OD1 ASP L 63 CA CA L 201 1555 1555 2.64
LINK OD2 ASP L 63 CA CA L 201 1555 1555 2.40
LINK O GLN L 64 CA CA L 201 1555 1555 2.36
LINK CA CA L 201 O HOH L 344 1555 1555 2.38
LINK CA CA L 206 O HOH L 301 1555 4556 2.30
CISPEP 1 PHE H 256 PRO H 257 0 0.12
CISPEP 2 GLU T 26 PRO T 27 0 0.07
CRYST1 70.993 81.302 125.860 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.014086 0.000000 0.000000 0.00000
SCALE2 0.000000 0.012300 0.000000 0.00000
SCALE3 0.000000 0.000000 0.007945 0.00000